Company news
Easton Pharmaceuticals Inc news in 2015
Easton Pharmaceuticals Inc's news releases, calls and decks from 2015, newest first.
Easton Pharmaceuticals Letter to Shareholders and Update
October 7, 2015
Easton Pharmaceuticals Announces Finalized Agreement to Secure All of Spanish-Speaking Latin America, Adding to Its Mexico Rights for the VS-Senses Patented Women's Vaginal Health Diagnostic Test
September 15, 2015
Easton Pharmaceuticals Closes on First Wholesale Sales Order for Skin Renou HA for Mexico and Other Latin American Countries With BMV Medica
August 26, 2015
Easton Pharmaceuticals Announces Major Initiative Supporting Its Focus on Unique Patented Women's Health Products With the Appointment of Dr. Jose Tiran as Founding Member of Easton's Medical/Scientific Advisory Board in Women's Health
August 17, 2015
Easton Pharmaceuticals and BMV Medica Finalize License Agreement With CommonSense Ltd. of Israel to Be Sole Distributor for Patented AL-Sense (Amnio-Sense-Blue) Amniotic Fluid Leak Test for Latin America
August 4, 2015
Easton Pharmaceuticals Announces the Appointment of Evan Karras as CEO / Director and Mr. Nunzio Valerie as President / CFO; Mr. Karras Possesses a Strong Background in Canadian and International Commercial Successes and Is Expected to Make Major Impact o
July 29, 2015
Easton Pharmaceuticals / BMV Medica Announces Its Mexican Ministry of Health and Latin America Regulatory Filing and Approval Process for Cancer Drugs Paclitaxel and Docetaxel From Biolyse Pharma Has Been Shortened
July 6, 2015
Easton Pharmaceuticals and BMV Medica Announce Eva Pro as Brand Name for Its Line of Patented Women's Diagnostic Tests for the Mexican and Other Latin American Markets; Trademark Registration of Individual Product Names, Logos and Packaging Has Commenced
June 23, 2015
Easton Pharmaceuticals and BMV Medica Sign MOU Towards Exclusive Distribution for Woman's Patented Diagnostic Test for Amniotic Fluid Detection for Women in Late Pregnancy for the Majority of Latin American Countries
June 18, 2015
Easton Pharmaceuticals Moves to Directly Negotiate Exclusive Agreement With Private Medical Marijuana Grower in Canada as a Result of Galileo Life Science's Actions Toward Its Previously Executed Option and Purchase Agreement; Provides Formal Action Respo
June 17, 2015
Easton Pharmaceuticals and BMV Medica Close on Joint Distribution Agreement for Injectable Approved Cancer Drugs for Mexico and Other Latin American Countries With Biolyse Pharma Corporation
June 15, 2015
Easton Pharmaceuticals Signs MOU Towards Distributing a Line of Injectable Approved Cancer Drugs for Mexico and Other Latin American Countries; Further Announces It Is Not Canceling Its Canadian Medical Marijuana Option With MDRM, Stays Committed To Medic
June 8, 2015
Easton Pharmaceuticals Announces It Has Provided Notification and Entered Into Discussions to Terminate Its Canadian Medical Marijuana Option Agreement With MDRM Canada
June 1, 2015
Easton Pharmaceuticals Announces Successful Launch of Its First 3 OTC Products at Recently Attended Trade Shows, the Total Health Show and Yoga Shows; Proceeds Towards Completion of Its 2014 Year End Audit
April 28, 2015
Easton Pharmaceuticals Announces Finalized Joint Partnership Agreement With BMV Medica for Exclusive Rights to Distribute World Patented Women's Health Diagnostic Test in Mexico From Israel-Based Common Sense Ltd.
April 22, 2015
Easton Pharmaceuticals Announces a Signed Agreement With Colorado Product Services, LLC and Cultiv8, LLC Towards the Purchase of a Recreational Marijuana Dispensary, Cultivation Facility and Lab in Carbondale, Colorado
April 20, 2015
Easton Pharmaceuticals Announces North American Products Distribution and Intellectual Property Agreement With NutraShop Global Stores, a Large Online Quality Wellness and Therapeutic Products Retailer; Provides Other Updates
March 19, 2015
Easton Pharmaceuticals Announces Memorandum of Understanding With Broken Coast Cannabis Ltd, a Health Canada Licensed MMPR Provider
March 16, 2015
Easton Pharmaceuticals Inc. Provides Update on the AMFIL GroZone Technology for the Medical Marijuana Industry and Moves Towards Implementation Within Medicated Markets California Operations
March 2, 2015
Easton Pharmaceuticals Discloses Existing Medicated Market Revenues From Its Medical Marijuana Operations That Have Surpassed $2,000,000; Provides Clarification on Other Items
February 24, 2015
Easton Pharmaceuticals Unveils Medicated Markets Revenue Projections for Fiscal 2015
February 17, 2015
Easton Pharmaceuticals Provides Update on Its Medicated Markets Partnership, Joint Initiatives and the Booming Medical Marijuana Climate in California for January 2015
February 9, 2015
Easton Pharmaceuticals Releases December Vaporizer Sales, Highlighting a 62% Month Over Month Increase in Revenues on Fiscal 2014 Vaporizer Segment Revenues
February 5, 2015
Easton Pharmaceuticals Discloses List of Joint Initiatives With Medicated Markets International LLC, Its California Based Medical Marijuana Partner
January 28, 2015
Easton Pharmaceuticals Inc Is Pleased to Announce Definitive Finalized Agreement With Medicated Markets International LLC, a Major California Based Medical Marijuana Grower
January 20, 2015
Easton Pharmaceuticals Provides Medicated Markets Due Diligence Update With the Disclosure of Total Number of Plants, Strains and Dispensaries Currently Being Serviced
January 12, 2015